Abstract
Simulations can provide detailed insight into the molecular processes involved in drug action, such as protein-ligand binding, and can therefore be a valuable tool for drug design and development. Processes with a large range of length and timescales may be involved, and understanding these different scales typically requires different types of simulation methodology. Ideally, simulations should be able to connect across scales, to analyze and predict how changes at one scale can influence another. Multiscale simulation methods, which combine different levels of treatment, are an emerging frontier with great potential in this area. Here we review multiscale frameworks of various types, and selected applications to biomolecular systems with a focus on drug-ligand binding.
| Original language | English |
|---|---|
| Pages (from-to) | 213-221 |
| Number of pages | 9 |
| Journal | Current Opinion in Structural Biology |
| Volume | 61 |
| Early online date | 26 Feb 2020 |
| DOIs | |
| Publication status | Published - Apr 2020 |
Bibliographical note
Copyright © 2020. Published by Elsevier Ltd.Research Groups and Themes
- Physical & Theoretical
Fingerprint
Dive into the research topics of 'Multiscale simulation approaches to modeling drug-protein binding'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver